Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Research Square|November 21, 2023
Estimands for clinical endpoints in Tuberculosis treatment randomized controlled trials: a retrospective application in a completed trialIsabelle R Weir, Suzanne M Dufault, Patrick Pj Phillips
Statistical Methods in Medical Research|June 1, 2026
An evaluation of designs for Phase I/IIa dose-finding studies in TuberculosisAlessandra Serra, Pavel Mozgunov, Patrick Pj Phillips, et al.
Clinical Trials (London, England)|June 6, 2023
Handling intercurrent events and missing data in non-inferiority trials using the estimand framework: A tuberculosis case studySunita Rehal, Suzie Cro, Patrick Pj Phillips, et al.
Clinical Trials (London, England)|June 7, 2018
Rethinking non-inferiority: a practical trial design for optimising treatment durationMatteo Quartagno, A Sarah Walker, James R Carpenter, et al.
Clinical Trials (London, England)|July 19, 2022
Rethinking intercurrent events in defining estimands for tuberculosis trialsTra My Pham, Conor D Tweed, James R Carpenter, et al.
Bulletin of the World Health Organization|September 2, 2024
Drug-resistant tuberculosis treatments, the case for a phase III platform trialTom A Yates, Samara Barnes, Martin Dedicoat, et al.
Bulletin of the World Health Organization|June 10, 2020
Economic evaluation of short treatment for multidrug-resistant tuberculosis, Ethiopia and South Africa: the STREAM trialJason J Madan, Laura Rosu, Mamo Girma Tefera, et al.
Medrxiv : the Preprint Server for Health Sciences|August 16, 2024
Adverse events reported during weekly isoniazid-rifapentine (3HP) tuberculosis preventive treatment among people living with HIV in UgandaJillian L Kadota, Allan Musinguzi, Hélène E Aschmann, et al.
Clinical Trials (London, England)|August 24, 2017
Testing many treatments within a single protocol over 10 years at MRC Clinical Trials Unit at UCL: Multi-arm, multi-stage platform, umbrella and basket protocolsMahesh Kb Parmar, Matthew R Sydes, Fay H Cafferty, et al.
American Journal of Respiratory and Critical Care Medicine|March 13, 2025
Efficacy and Safety of Higher Doses of Levofloxacin for MDR-TB: A Randomized Placebo-controlled Phase 2 TrialPatrick Pj Phillips, Charles A Peloquin, Timothy R Sterling, et al.
Pageof 2